Efficacy of favipiravir-based drugs against COVID-19 confirmed by clinical trials in Russia and Japan
Avifavir already delivered to Belarus, Bolivia, Kazakhstan, Kyrgyzstan, Turkmenistan and Uzbekistan, deliveries to 17 more countries expected
MOSCOW, Sept. 24, 2020 /PRNewswire/ — The Russian Direct